IP Library Granted Patent US 8,900,865
Granted Patent B2
US 8,900,865 · App. 11/389,268 · Granted Dec 2, 2014

Blood brain barrier device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,900,865
App. No.
11/389,268
Granted
Dec 2, 2014
Kind
B2
Abstract

Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to subjects.

Claims (32)

1. A device, comprising:

a bone cage defining an internal cavity;

one or more biologically active molecules disposed in the internal cavity of the bone cage; and

a semi-permeable component including brain endothelial cells having one or more characteristics of a blood brain barrier capillary endothelium, the semi-permeable component at least partially enclosing or at least partially enclosed by the bone cage, the semi-permeable component being selectively permeable to the one or more biologically active molecules to allow passage of the one or more biologically active molecules out of the bone cage.

2. The device of claim 1 , wherein the one or more characteristics of the blood brain barrier capillary endothelium is not a characteristic of peripheral capillary endothelium.

3. The device of claim 2 , wherein the one or more characteristics of the blood brain barrier capillary endothelium that is not a characteristic of peripheral capillary endothelium further includes one or more of fenestrations or polarity between luminal and abluminal surfaces.

4. The device of claim 1 , wherein the abluminal surface of the blood brain barrier capillary endothelium is oriented toward the internal cavity.

5. The device of claim 1 , for implantation in a subject, wherein the semi-permeable component is autologous, allogeneic or xenogeneic with respect to the subject.

6. The device of claim 5 , wherein the subject is an animal.

7. The device of claim 6 , wherein the animal is selected from the group consisting of a domesticated animal, a farm animal, a marine animal, a sport animal, a wild animal, a research animal, a zoo animal, a bird, an amphibian, a reptile, a fish and a mammal.

8. The device of claim 7 , wherein the mammal is a human.

9. The device of claim 1 , wherein the semi-permeable component is genetically engineered.

10. The device of claim 1 , wherein the semi-permeable component is designed to at least partially enhance restructuring.

11. The device of claim 1 , for implantation in a subject, wherein the semi-permeable component is non-immunogenic with respect to the subject.

12. The device of claim 1 , for implantation in a subject, wherein the semi-permeable component is recognized as self by the subject.

13. The device of claim 1 , wherein the device is implantable.

14. The device of claim 1 , wherein the device is biocompatible.

15. The device of claim 1 , further comprising one or more living cells or tissues.

16. The device of claim 15 , wherein the one or more living cells or tissues are at least partially located in the internal cavity.

17. The device of claim 15 , for implantation in a subject, wherein the one or more living cells or tissues are autologous, allogeneic or xenogeneic with respect to the subject.

18. The device of claim 17 , wherein the subject is an animal.

19. The device of claim 18 , wherein the animal is selected from the group consisting of a domesticated animal, a farm animal, a marine animal, a sport animal, a wild animal, a research animal, a zoo animal, a bird, an amphibian, a reptile, a fish and a mammal.

20. The device of claim 19 , wherein the mammal is a human.

21. The device of claim 15 , wherein the one or more living cells or tissues are genetically engineered.

22. The device of claim 15 , for implantation in a subject, wherein the one or more living cells or tissues deliver one or more biologically active molecules to the subject.

23. The device of claim 15 , for implantation in a subject, wherein the one or more living cells or tissues are non-immunogenic with respect to the subject.

24. The device of claim 15 , for implantation in a subject, wherein the one or more living cells or tissues are recognized as self by the subject.

25. The device of claim 1 , wherein the bone cage includes living bone cells.

26. An implantable device, comprising:

one or more biologically active materials that do not include bone tissue, wherein the one or more biologically active materials include at least one of biologically active molecules or cells;

a porous bone cage at least partially forming an internal cavity having the one or more biologically active materials disposed therein, the porous bone cage including a scaffold with living bone cells having decreased immunogenicity, the porous bone cage configured to selectively allow passage of the one or more biologically active materials therethrough; and

a semi-permeable component including brain endothelial cells having one or more characteristics of a blood brain barrier capillary endothelium, the semi-permeable component at least partially enclosing or at least partially enclosed by the bone cage, the semi-permeable component being selectively permeable to the one or more biologically active materials to allow passage of the one or more biologically active materials out of the bone cage.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2014
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 033672/0580 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2006
From: HARLOW, ED; HYDE, RODERICK A.; JUNG, EDWARD K.Y.; LANGER, ROBERT; LEUTHARDT, ERIC C.; WOOD, JR., LOWELL L.
To: SEARETE LLC
Reel/Frame 017865/0682 →